PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Respiratory and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.\', \'Prevention of Organ Failure (PROOF) Centre of Excellence and Centre for Heart Lung Innovation, St Paul\'s Hospital, University of British Columbia, Vancouver, BC, Canada.\', \'Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.\', \'Systems Vaccinology, Center for Precision Health, Telethon Kids Institute, Nedlands, WA, Australia.\', \'Toronto General Hospital Research Institute, University Health Network and Department of Immunology, University of Toronto, Toronto, ON, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2020.01061
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 32574262
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Interferon-α2b Treatment for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32574262>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32574262>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all